The number of liver cancer cases in Africa will double by 2050 unless steps are taken now to treat Hepatitis B

Hepatitis B is an urgent public health issue

Prolifica is a 5 year European Commision (EC) funded medical research programme to look at the link between viral hepatitis and liver cancer

The aim of the study is to reduce the risk of liver cancer in Africa by the suppression of Hepatitis B infection

We also hope to help develop diagnostics for detecting cancer in resource-poor countries